lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

Positive Epstein-Barr Virus Detection in Corona Virus Disease 2019 (COVID-19) Patients

15 Pages Posted: 30 Mar 2020

See all articles by Ting Chen

Ting Chen

Wuhan University - Department of Ophthalmology

Jiayi Song

Wuhan University - Renmin Hospital

Hongli Liu

Wuhan University - Renmin Hospital

Hongmei Zheng

Wuhan University - Renmin Hospital

Changzheng Chen

Wuhan University - Department of Ophthalmology

More...

Abstract

Background: The pathological report suggested severe immune injury in corona virus disease 2019 (COVID-19) patients. Epstein-Barr virus (EBV) reactivation has been reported in immunocompromised individuals. We aimed to detect EBV coinfection in COVID-19 patients.

Methods: In this single-centered, retrospective, observational study, COVID-19 patients were enrolled in our study. The characteristics of the demographic, symptoms, signs, laboratory and CT results and clinical outcome were collected. Data were compared between EBV seropositive and seronegative COVID-19 patients.

Findings: Of 196 patients, 62 COVID-19 patients were included in our study. The median age was 37 years, with 32 (51 · 6%) females. Among these COVID-19 patients, 35 (56 · 5%) patients were seropositive for EBV viral capsid antigen (VCA) IgM antibody. EBV seropositive COVID-19 patients had a 3 · 64-fold risk of having a fever symptom than EBV seronegative (95%CI, 1 · 26-10 · 51; P=0 · 02). C-reactive protein (CRP) in EBV seropositive COVID-19 patients were higher than EBV seronegative patients (P=0 · 01). The proportion of CD8 (CD8%) was statistically significant lower in EBV seropositive COVID-19 patients (P=0 · 048). The CD4/CD8 in EBV seropositive COVID-19 patients was lower than that in EBV seronegative patients (P=0 · 046). 25 (40 · 3%) were discharged before February 29, 2020. The median recovery time in EBV seropositive COVID-19 patients (24 days) was higher than that in EBV seronegative COVID-19 patients (19 days), while the difference was not significant (P=0 · 07).

Interpretation: EBV acute infection was found in COVID-19 patients. EBV seropositivity was associated with fever, increased inflammation and cellular immune response in COVID-19 patients. EBV reactivation should be considered in treating COVID-19.

Funding Statement: None.

Declaration of Interests: The authors confirmed that no competing financial interests exist.

Ethics Approval Statement: The study was approved by the ethical committee board of Renmin Hospital of Wuhan University (WDRY2020-K073).

Keywords: COVID-19; Epstein-Barr virus; coinfection; immune function

Suggested Citation

Chen, Ting and Song, Jiayi and Liu, Hongli and Zheng, Hongmei and Chen, Changzheng, Positive Epstein-Barr Virus Detection in Corona Virus Disease 2019 (COVID-19) Patients (3/12/2020). Available at SSRN: https://ssrn.com/abstract=3555268 or http://dx.doi.org/10.2139/ssrn.3555268

Ting Chen

Wuhan University - Department of Ophthalmology

Wuhan
China

Jiayi Song

Wuhan University - Renmin Hospital

Wuhan, Hubei
China

Hongli Liu

Wuhan University - Renmin Hospital

Wuhan, Hubei
China

Hongmei Zheng

Wuhan University - Renmin Hospital

Wuhan, Hubei
China

Changzheng Chen (Contact Author)

Wuhan University - Department of Ophthalmology ( email )

Wuhan
China
(86) 027-88041911 (Phone)

Click here to go to TheLancet.com

Paper statistics

Abstract Views
9,217
Downloads
649
PlumX Metrics